SCHEMBL1924903

SCHEMBL1924903

NC(=O)c1[nH]cc(C(=O)O)c1-c1ccc(NC(=O)Nc2ccccc2C(F)(F)F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.47
MEN1 O00255 2/20 0.47
KMT2A Q03164 2/20 0.47
GRIK1 P39086 2/20 0.47
NPC1 O15118 1/20 0.47
ALDH1A1 P00352 1/20 0.47
THRB P10828 1/20 0.47
RAB9A P51151 1/20 0.47
NOX1 Q9Y5S8 1/20 0.47
DGAT1 O75907 3/20 0.47
KDR P35968 2/20 0.46
FLT3 P36888 2/20 0.46
PLK4 O00444 1/20 0.46
ROCK2 O75116 1/20 0.46
MAP4K4 O95819 1/20 0.46
LCK P06239 1/20 0.46
CSF1R P07333 1/20 0.46
ROS1 P08922 1/20 0.46
FGFR1 P11362 1/20 0.46
FLT1 P17948 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1925492 0.91 CA12 (0.53) KDM4EMEN1KMT2AGRIK1NPC1
SCHEMBL1925903 0.86 NPC1 (0.51) KDM4EMEN1KMT2AGRIK1NPC1
SCHEMBL1924209 0.86 MEN1 (0.49) KDM4EMEN1KMT2ANPC1ALDH1A1
SCHEMBL1924738 0.85 EPHX2 (0.51) MEN1KMT2AGRIK1RAB9ADGAT1
SCHEMBL1924222 0.84 KDR (0.49) KDM4EMEN1KMT2ANPC1RAB9A
SCHEMBL1923695 0.84 CDK8 (0.47) KDRFLT3LCKCSF1RFGFR1
SCHEMBL1924459 0.84 KDM4E (0.46) KDM4EMEN1KMT2ANPC1ALDH1A1
SCHEMBL1926566 0.83 KDR (0.56) KDRFLT1CA1CA2CA9
SCHEMBL1924133 0.83 TAS2R14 (0.45) MEN1KMT2AKDRFLT3LCK
SCHEMBL1923760 0.82 MEN1 (0.56) MEN1KMT2AGRIK1ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1856043-B1 1-H-PYRROLE-2-CARBOXAMIDES AND IMIDAZOLE-5-CARBOXAMIDES AND USE THEREOF AS FAK, KDR AND TIE2 KINASE MODULATORS FOR THE TREATMENT OF CANCER AVENTIS PHARMA SA (FR) 2011-06-08 EP claimed
EP-1856043-A1 1-H-PYRROLE-2-CARBOXAMIDES AND IMIDAZOLE-5-CARBOXAMIDES AND USE THEREOF AS FAK, KDR AND TIE2 KINASE MODULATORS FOR THE TREATMENT OF CANCER Aventis Pharma S.A. (FR) 2007-11-21 EP claimed
WO-2006082309-A1 1-H-PYRROLE-2-CARBOXAMIDES AND IMIDAZOLE-5-CARBOXAMIDES AND USE THEREOF AS FAK, KDR AND TIE2 KINASE MODULATORS FOR THE TREATMENT OF CANCER AVENTIS PHARMA SA (FR) 2006-08-10 WO claimed
EP-1856043-B1 1-H-PYRROLE-2-CARBOXAMIDES AND IMIDAZOLE-5-CARBOXAMIDES AND USE THEREOF AS FAK, KDR AND TIE2 KINASE MODULATORS FOR THE TREATMENT OF CANCER AVENTIS PHARMA SA (FR) 2011-06-08 EP disclosed
EP-1856043-A1 1-H-PYRROLE-2-CARBOXAMIDES AND IMIDAZOLE-5-CARBOXAMIDES AND USE THEREOF AS FAK, KDR AND TIE2 KINASE MODULATORS FOR THE TREATMENT OF CANCER Aventis Pharma S.A. (FR) 2007-11-21 EP disclosed
WO-2006082309-A1 1-H-PYRROLE-2-CARBOXAMIDES AND IMIDAZOLE-5-CARBOXAMIDES AND USE THEREOF AS FAK, KDR AND TIE2 KINASE MODULATORS FOR THE TREATMENT OF CANCER AVENTIS PHARMA SA (FR) 2006-08-10 WO disclosed